IGFBP3 and colorectal carcinoma: Contrastingly, in another study for stages II and III CRC patients who had received 5-fluorouracil- (5-FU-) based adjuvant chemotherapy, low IGFBP3 methylation levels were associated with longer overall survival (P = 0.0007) and disease-free survival (P = 0.05).